Relationship between size of myocardial infarctions assessed by delayed contrast-enhanced MRI after primary PCI, biochemical markers, and time to intervention

Journal of Interventional Cardiology

Volumn 17, Issue 6, 2004, Pages 367-373

  Haase, Jürgen ^a,d   Bayar, Rusen ^b   Hackenbroch, Matthias ^c   Störger, Hans ^a   Hofmann, Manfred ^a   Schwarz, Claus Eberhard ^a   Reinemer, Harald ^a   Schwarz, Franz ^a   Ruef, Johannes ^a   Sommer, Torsten ^c  

^a Red Cross Hospital Cardiology Center   (Germany)

^b SANOFI   (France)

^c UNIVERSITY OF BONN   (Germany)

^d Klinik Rotes Kreuz   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; CLOPIDOGREL; CREATINE KINASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GADOLINIUM; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ABSOLUTE HEART INFARCTION SIZE; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CORONARY STENT; CORRELATION ANALYSIS; DELAYED CONTRAST ENHANCED NUCLEAR MAGNETIC RESONANCE IMAGING; FEMALE; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE; HUMAN; LINEAR REGRESSION ANALYSIS; LOW DRUG DOSE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RELATIVE HEART INFARCTION SIZE; ST SEGMENT ELEVATION; ST SEGMENT ELEVATION HEART INFARCTION; THREE DIMENSIONAL IMAGING; THREE DIMENSIONAL INVERSION RECOVERY GRADIENT ECHO MAGNETIC RESONANCE;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBODIES, MONOCLONAL; C-REACTIVE PROTEIN; CREATINE KINASE; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIUM; NECROSIS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROSPECTIVE STUDIES;

EID: 9244263004     PISSN: 08964327     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2004.04078.x     Document Type: Article

References (17)

1. Le May MR, Labinaz M, Richard FA, et al. Stenting versus thrombolysis in acute myocardial infarction trial (STAT). J Am Coll Cardiol 2001;37:985-991.
2. Kastrati A, Mehilli J, Dirschinger J, et al. Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: A randomized trial. Lancet 2002;359:920-925.
3. Williams ES, Miller JM. Results from late breaking clinical trials at the American College 51st Annual Scientific Session. J Am Coll Cardiol 2002;40:1-18.
4. Morishima I, Sone T, Okumura K, et al. Angiographic noreflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol 2000;36:1202-1209.
5. Haager PK, Christott P, Heussen N, et al. Prediction of clinical outcome after mechanical revascularization in acute myocardial infarction by markers of myocardial reperfusion. J Am Coll Cardiol 2003;41:532-538.
6. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100:1992-2002.
7. Mahrholdt H, Wagner A, Holly TA, et al. Reproducibility of chronic infarct size measurement by contrast-enhanced magnetic resonance imaging. Circulation 2002;106:2322-2327.
8. Shan K, Constantine G, Sivanathan M, et al. Role of magnetic resonance imaging in the assessment of myocardial viability. Circulation 2004;109:1328-1334.
9. Braunwald E, Kloner RA. The stunned myocardium: Prolonged, postischemic ventricular dysfunction. Circulation 1982;66:1146-1149.
10. Bolognese L, Neskovic AN, Parodi G, et al. Left ventricular remodeling after primary coronary angioplasty; patterns of left ventricular dilatation and long-term prognostic implications. Circulation 2002;106:2351-2357.
11. Ingkanisorn WP, Rhoads KL, Aletras AH, et al. Gadolinium delayed enhancement cardiovascular magnetic resonance correlates with clinical measures of myocardial infarction. J Am Coll Cardiol 2004;43:2253-2259.
12. Lindahl B, Toss H, Siegbahn A, et al. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC study group. Fragmin during instability in coronary artery disease. N Engl J Med 2000;343:1139-1147.
13. Cannon CP, Gibson CM, Lambrew CT, et al. Relationship of symptom-onset-to-ballon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 2000;283:2941-2947.
14. Brodie BR, Stuckey TD, Wall TC, et al. Importance of time to reperfusion for 30 day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 1998;32:1312-1319.
15. Brodie BR, Stone GW, Morice MC, et al. Importance of time to reperfusion on outcomes with primary coronary angioplasty for acute myocardial infarction (results from the Stent Primary Angioplasty in Myocardial Infarction Trial). Am J Cardiol 2001;88:1085-1090.
16. De Luca G, Suryapranata H, Zijlstra F, et al. Symptom-onset-to-ballon- time and mortality in patients with acute myocardial infarction treated by primary angioplasty. J Am Coll Cardiol 2003;42:991-997.
17. Roberts R. Enzymatic estimation of infarct size: Thrombolysis induced its demise - Will it now rekindle its renaissance? Circulation 1990;81:707-710.